Is a complete ENTA research report available?

No complete published report is available for Enanta Pharmaceuticals, Inc. (ENTA) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Enanta Pharmaceuticals, Inc. (ENTA)

NASDAQ: ENTA · USD

$12.8

-0.17 (-1.3%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-25 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first ENTA analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	371.6M
Revenue (ttm)	69.2M
Net income (ttm)	-62M
EPS (ttm)	-$2.47
Shares out	29.1M
Volume	104,646
Beta	0.97
Price target	$21.2	+65.6%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 69.2M
Net income (ttm): -62M
EPS (ttm): -$2.47
Market cap: 371.6M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All ENTA indicators

Market & fundamental data

Available fields

215

Groups with data

Currency

USD

Showing 215 of 215 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001177648
Company name	Enanta Pharmaceuticals, Inc.
Country	United States
Country code	US
Cusip	29251M106
Employees	120
Employees Change	-11%
Employees Change Percent	-8.4
Enterprise value	$331.2M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2013-03-21
Isin	US29251M1062
Last refreshed	2026-07-25
Market cap	$371.6M
Market cap category	Small-Cap
Price	$12.78
Price currency	USD
Rev Per Employee	576,775x
Sector	Healthcare
Sector PE	44.8
Sector PE Fwd	23.64
Sic	2834
Symbol	ENTA
Website	https://www.enanta.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-16.68%
EV Sales Forward	5.38x
EV/Sales	4.79x
FCF yield	-2.59%
P/B ratio	3.19x
P/S ratio	5.37x
PS Forward	6.04x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-87.24%
EBITDA Margin	-80.12%
Gross margin	100%
Gross Profit	$69.2M
Gross Profit Growth	7.37%
Gross Profit Growth Q	14.96%
Gross Profit Growth3 Y	-5.18%
Gross Profit Growth5 Y	-5.97%
Net Income	$-62M
Net Income Growth Quarters	6%
Net Income Growth Years	2%
Pretax Margin	-89.42%
Profit Margin	-89.56%
Profit Per Employee	$-516,533
ROA	-11.84
Roa5y	-17.73
ROCE	-22.51
ROE	-59
Roe5y	-50.76
ROIC	-44.18
Roic5y	-116.1

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-5.36%
Cagr1y	65.39%
Cagr3y	-12.07%
Cagr5y	-21.18%
EPS Growth Quarters	6
EPS Growth Years	2
Revenue Growth	7.37x
Revenue Growth Q	14.96x
Revenue Growth Quarters	4x
Revenue Growth Years	0x
Revenue Growth3 Y	-5.18x
Revenue Growth5 Y	-5.97x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.22
Assets	$314.7M
Cash	$163.8M
Current Assets	$178.4M
Current Liabilities	$46.4M
Debt	$186.6M
Debt Equity	$1.6
Equity	$116.6M
Interest Coverage	-5.8
Liabilities	$198.1M
Long Term Assets	$136.3M
Long Term Liabilities	$151.7M
Net Cash	$40.4M
Net Cash By Market Cap	$10.87
Net Debt Equity	$-0.35
Tangible Book Value	$116.6M
Tangible Book Value Per Share	$4.01
WACC	7.84

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.84
Net Working Capital	$3.4M
Quick ratio	3.69
Working Capital	$132M
Working Capital Turnover	$0.42

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-18.33%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-42.33%
1Y total return	65.33%
200-day SMA	13.27
3Y total return	-32.02%
50-day SMA	13.19
50-day SMA vs 200-day SMA	50under200
5Y total return	-69.57%
All Time High	127.8
All Time High Change	-90%
All Time High Date	2018-07-06
All Time Low	4.09
All Time Low Change	212.47%
All Time Low Date	2025-04-09
ATR	0.75
Beta	0.97
Beta1y	0.97
Beta2y	1.56
Ch YTD	-18.96
High	13.06
High52	17.15
High52 Date	2025-12-29
High52ch	-25.48%
Low	12.42
Low52	6.45
Low52 Date	2025-08-11
Low52ch	98.14%
Ma50ch	-3.08%
Price vs 200-day SMA	-3.71%
RSI	42.46
RSI Monthly	47.52
RSI Weekly	48.85
Sharpe ratio	0.83x
Sortino ratio	2.16
Total Return	-18.33%
Tr YTD	-18.96
Tr1m	-9.1%
Tr1w	-6.99%
Tr3m	-4.27%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	6
Analyst Count Top	1
Analyst Price Target Top	$19
Analyst Ratings	Strong Buy
Analyst Ratings Top	Buy
Earnings EPS Estimate	$-0.48
Earnings Revenue Estimate	17,591,200x
Earnings Revenue Estimate Growth	-3.95x
Operating Income	$-60.4M
Operating margin	-87.24
Price target	$21.17
Price Target Change	$65.65
Price Target Change Top	$48.67

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	20,059,005%
Float Percent	68.98%
Shares Insiders	4.55%
Shares Institutions	66.04%
Shares Out	29,078,380
Shares Qo Q	1.02%
Shares Yo Y	18.33%
Short Float	12.88%
Short Ratio	10.17
Short Shares	8.88

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-25.4M
Average Volume	228,564.15x
Bv Per Share	4.01
CAPEX	$-1.8M
Ch10y	-42.33
Ch1m	-9.1
Ch1w	-6.99
Ch1y	65.33
Ch3m	-4.27
Ch3y	-32.02
Ch5y	-69.57
Ch6m	-1.84
Change	-1.31%
Change From Open	-2.14
Close	12.95
Days Gap	0.85
Depreciation Amortization	4,933,000
Dollar Volume	1,337,375.9
Earnings Date	2026-08-10
Earnings Time	amc
EBIT	$-60.4M
EBITDA	$-55.5M
EPS	$-2.47
F Score	3
FCF	$-9.6M
FCF EV Yield	-2.9x
FCF Per Share	$-0.33
Financing CF	42,096,000
Fiscal Year End	September
Founded	1,995
Income Tax	$92,000
Investing CF	-59,543,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-11
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2025-11-19
Ma150	13.61
Ma150ch	-6.13%
Ma20	13.82
Ma20ch	-7.55%
Net CF	-25,285,000
Next Earnings Date	2026-08-10
Open	13.06
Optionable	Yes
Position In Range	56.25
Post Close	12.78
Postmarket Change Percent	0
Postmarket Price	$12.78
Ppne	69,550,000
Price Date	2026-07-24
Ptbv Ratio	3.19
Relative Volume	0.46x
Revenue	69,213,000x
SBC By Revenue	22.78x
Share Based Comp	15,769,000
Tax By Revenue	0.13x
Tr6m	-1.84%
Us State	Massachusetts
Volume	104,646
Z Score	-1.03

Enanta Pharmaceuticals, Inc. (ENTA)

Coverage state: Market snapshot only — no published research

Generate the first ENTA analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · ENTA

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ENTA indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on ENTA

Frequently asked questions